Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection

被引:42
作者
Costa, Vlaudia M. A.
Torres, Karen C. L.
Mendonca, Ronaldo Z.
Gresser, Ion
Gollob, Kenneth J.
Abrahamsohn, Ises A.
机构
[1] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508900 Sao Paulo, Brazil
[2] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil
[3] Inst Butantan, Sao Paulo, Brazil
[4] Univ Paris 06, Ctr Rech Biomed Cordeliers, Paris, France
关键词
D O I
10.4049/jimmunol.177.5.3193
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The participation of type I IFNs (IFN-I) in NO production and resistance to Trypanosoma cruzi infection was investigated. Adherent cells obtained from the peritoneal cavity of mice infected by the i.p. route produced NO and IFN-I. Synthesis of NO by these cells was partially inhibited by treatment with anti-IFN-alpha beta or anti-TNF-alpha Abs. Compared with susceptible BALB/c mice, peritoneal cells from parasite-infected resistant C57BL/6 mice produced more NO (2-fold), IFN-I (10-fold), and TNF-alpha (3.5-fold). Later in the infection, IFN-I levels measured in spleen cell (SC) cultures from 8-day infected mice were greater in C57BL/6 than in infected BALB/c mice, and treatment of the cultures with anti-IFN-alpha beta Ab reduced NO production. IFN-gamma or IL-10 production by SCs was not different between the two mouse strains; IL-4 was not detectable. Treatment of C57BL/6 mice with IFN-I reduced parasitemia levels in the acute phase of infection. Mice deprived of the IFN-alpha beta R gene developed 3-fold higher parasitemia levels in the acute phase in comparison with control 129Sv mice. Production of NO by peritoneal macrophages and SCs was reduced in mice that lacked signaling by IFN-alpha beta, whereas parasitism of macrophages was heavier than in control wild-type mice. We conclude that IFN-I costimulate NO synthesis early in T. cruzi infection, which contributes to a better control of the parasitemia in resistant mice.
引用
收藏
页码:3193 / 3200
页数:8
相关论文
共 51 条
[31]   M-1/M-2 macrophages and the Th1/Th2 paradigm [J].
Mills, CD ;
Kincaid, K ;
Alt, JM ;
Heilman, MJ ;
Hill, AM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6166-6173
[32]   FUNCTIONAL-ROLE OF TYPE-I AND TYPE-II INTERFERONS IN ANTIVIRAL DEFENSE [J].
MULLER, U ;
STEINHOFF, U ;
REIS, LFL ;
HEMMI, S ;
PAVLOVIC, J ;
ZINKERNAGEL, RM ;
AGUET, M .
SCIENCE, 1994, 264 (5167) :1918-1921
[33]   ACTIVATION OF HUMAN MACROPHAGES FOR THE KILLING OF INTRACELLULAR TRYPANOSOMA-CRUZI BY TNF-ALPHA AND IFN-GAMMA THROUGH A NITRIC OXIDE-DEPENDENT MECHANISM [J].
MUNOZFERNANDEZ, MA ;
FERNANDEZ, MA ;
FRESNO, M .
IMMUNOLOGY LETTERS, 1992, 33 (01) :35-40
[34]   Type IIFNs and regulation of THI responses:: enigmas both resolved and emerge [J].
O'Shea, JJ ;
Visconti, R .
NATURE IMMUNOLOGY, 2000, 1 (01) :17-19
[35]   Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosama cruzi glycoinositolphospholipids and higher resistance to infection with T-cruzi [J].
Oliveira, AC ;
Peixoto, JR ;
de Arruda, LB ;
Campos, MA ;
Gazzinelli, RT ;
Golenbock, DT ;
Akira, S ;
Previato, JO ;
Mendonça-Previato, L ;
Nobrega, A ;
Bellio, M .
JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5688-5696
[36]   ROLE OF NITRIC-OXIDE IN RESISTANCE AND HISTOPATHOLOGY DURING EXPERIMENTAL-INFECTION WITH TRYPANOSOMA-CRUZI [J].
PETRAY, P ;
CASTANOSVELEZ, E ;
GRINSTEIN, S ;
ORN, A ;
ROTTENBERG, ME .
IMMUNOLOGY LETTERS, 1995, 47 (1-2) :121-126
[37]   Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection [J].
Pinge, P ;
Tadokoro, CE ;
Abrahamsohn, IDA .
CELLULAR IMMUNOLOGY, 1999, 193 (01) :90-98
[38]  
Reed SG, 1998, CHEM IMMUNOL, V70, P124
[39]   The evolution of the type I interferons [J].
Roberts, RM ;
Liu, LM ;
Guo, QT ;
Leaman, D ;
Bixby, J .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (10) :805-816
[40]   Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities [J].
Roggero, E ;
Perez, A ;
Tamae-Kakazu, M ;
Piazzon, I ;
Nepomnaschy, I ;
Wietzerbin, J ;
Serra, E ;
Revelli, S ;
Bottasso, O .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (03) :421-428